Skip to main content
OpenTrials

Clinical trial condition

Allogeneic, Hematopoietic Cell Transplant (HCT)

Explore clinical trials studying Allogeneic, Hematopoietic Cell Transplant (HCT). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Allogeneic, Hematopoietic Cell Transplant (HCT) trial results

Completed

A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)

NCT01877655

Conditions
Allogeneic, Hematopoietic Cell Transplant (HCT), Cytomegalovirus (CMV)-Positive Recipients
Locations
  • Site US10028 Birmingham, Alabama, United States
  • Site US10044 Tucson, Arizona, United States
  • Site US10035 San Francisco, California, United States
  • Site US10026 Stanford, California, United States
View all 83 locations
View Trial Details

Related conditions